Search

Not so much a geological specimen as something that will make nanotechnology happen, dendrimers are the young upstarts of the polymer family - but they have promise.

There's nothing light about the scope and ambitions of the University of Manchester's new interdisciplinary Photon Science Institute. The £40 million institute aims to be world-class in pioneering light and laser technologies.

Nanotechnology has the power to transform healthcare. But Europe will lose out to the United States unless it can mount a coherent approach to developing nanomedicine, says a new report.

Scientists at the University of Manchester have invented an electronic nose that can monitor odours and methane at waste landfill and water treatment plants remotely.

Researchers at the University of Bonn in Germany have succeeded in finding a potentially low-cost source of a potent antiviral compound known to prevent replication of the HIV virus in vitro.

Last month the world's leading pharmaceutical company received simultaneous FDA approval for two new therapies. Yet neither drug was invented by the company. Both were originally developed by small biotechs.

The founding dean of INSEAD's Singapore campus is moving to the UK to head up the Judge Business School at Cambridge.

TU Delft ditched the usual model of outlicensing or seeking venture capital backing when it was looking to commercialise a novel wastewater treatment technology.

Dental implant company Neoss Ltd raised £5 million in its third funding round, enabling it to further develop the technology and expand its sales and marketing operations.

A pre-designed biomanufacturing facility with advance planning permission is the latest carrot devised by the Industrial Development Authority (IDA) Ireland in its efforts to attract international biopharmaceutical manufacturing projects.

Researchers at the Advanced Technology Institute at the University of Surrey recently reported that they have shown and observed a phenomenon called negative differential resistance - holding out the prospect of a new generation of cheap and fast semiconductors.

The UK's stem cell community has reacted with collective dismay at the final confirmation that Hwang Woo-suk's claims to have generated patient-specific embryonic stem cell lines were fraudulent. Nuala Moran takes a look.

For some it was like a very bad Greek tragedy, for others a hoax more naive than the Piltdown man. But Hwang Wo-suk's fall from grace puts the UK on level terms with South Korea in the race to generate embryonic stem cells from cloned embryos.

The concept of angel investing - in which individuals devote both their time and money to nurturing young companies - has evolved over the past decade from an unknown or poorly understand phenomena in many parts of Europe to an established form of finance.

Venture capital firms used to moan that business angels were unprofessional and hard to work with. But Europe's new breed of angel investor networks appears anything but that, says Mary Lisbeth D'Amico

Marc Van Montagu, Europe's founding father of genetically modified crops and a powerful advocate for their acceptance in Europe, speaks to Science|Business News Editor Thomas Lau.